Health TrialsbyHealthPanel

The GErman Italian Spanish Takotsubo (GEIST) Registry

ConditionTakotsubo Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorProf. Dr. med. Ingo Eitel

About this trial

GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with Takotsubo syndrome

Disqualifiers

Non

Trial population

Diagnosed according to the current diagnostic recommendations at the time of clinical presentation

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

All-cause mortality

All-cause mortality (in-hospital, short-term, long-term)

Time frame
Day 0
2

All-cause mortality

All-cause mortality (in-hospital, short-term, long-term)

Time frame
3 Month
3

All-cause mortality

All-cause mortality (in-hospital, short-term, long-term)

Time frame
6 Month

Secondary outcomes

1

In-Hospital complications

Cardiogenic shock, pulmonary edema, death, life-threatening arrhythmias, ventricular thrombus formation, right ventricular involvement

Time frame
Day 0

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Prof. Dr. med. Ingo Eitel

Lead sponsor

University of Luebeck

Sponsor institution

University of Foggia

Collaborator

Source ClinicalTrials.gov
Apply now